These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30836916)

  • 21. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
    Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
    Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
    Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurposing artemisinin as an anti-mycobacterial agent in synergy with rifampicin.
    Patel YS; Mistry N; Mehra S
    Tuberculosis (Edinb); 2019 Mar; 115():146-153. PubMed ID: 30948170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH.
    Al-Balas Q; Anthony NG; Al-Jaidi B; Alnimr A; Abbott G; Brown AK; Taylor RC; Besra GS; McHugh TD; Gillespie SH; Johnston BF; Mackay SP; Coxon GD
    PLoS One; 2009; 4(5):e5617. PubMed ID: 19440303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR based design of new antitubercular compounds: improved isoniazid derivatives against multidrug-resistant TB.
    Martins F; Ventura C; Santos S; Viveiros M
    Curr Pharm Des; 2014; 20(27):4427-54. PubMed ID: 24245762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
    Kumar G; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
    Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
    Kazakova OB; Medvedeva NI; Smirnova IE; Lopatina TV; Veselovsky AV
    Med Chem; 2021; 17(2):134-145. PubMed ID: 31939731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of thiophene based small molecules as potent inhibitors of Mycobacterium tuberculosis.
    Meena CL; Singh P; Shaliwal RP; Kumar V; Kumar A; Tiwari AK; Asthana S; Singh R; Mahajan D
    Eur J Med Chem; 2020 Dec; 208():112772. PubMed ID: 32920342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of novel N' (4-aryloxybenzylidene)- 1H-benzimidazole-2 carbohydrazide derivatives as anti-tubercular agents.
    Siddiki AA; Bairwa VK; Telvekar VN
    Comb Chem High Throughput Screen; 2014; 17(7):630-8. PubMed ID: 24625232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
    Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of in vitro antitubercular agents through in silico ligand-based approaches.
    De Vita D; Pandolfi F; Cirilli R; Scipione L; Di Santo R; Friggeri L; Mori M; Fiorucci D; Maccari G; Arul Christopher RS; Zamperini C; Pau V; De Logu A; Tortorella S; Botta M
    Eur J Med Chem; 2016 Oct; 121():169-180. PubMed ID: 27240272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
    Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
    Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs.
    Kang YG; Park CY; Shin H; Singh R; Arora G; Yu CM; Lee IY
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3650-3. PubMed ID: 26199118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.
    Hassan NW; Saudi MN; Abdel-Ghany YS; Ismail A; Elzahhar PA; Sriram D; Nassra R; Abdel-Aziz MM; El-Hawash SA
    Bioorg Chem; 2020 Mar; 96():103610. PubMed ID: 32028062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.